| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12:30 | Kestra Medical appoints Curtis Kopf as SVP of customer experience | 1 | Investing.com | ||
| 12:06 | Kestra Medical Technologies, Ltd.: Kestra Appoints Curtis Kopf as Senior Vice President of Customer Experience | 177 | GlobeNewswire (Europe) | KIRKLAND, Wash., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced the appointment... ► Artikel lesen | |
| 10.08. | JPMorgan startet Bewertung für Kestra Medical mit "Overweight" - Potenzial bei Medizingerät im Fokus | 2 | Investing.com Deutsch | ||
| 10.08. | JPMorgan initiates Kestra Medical stock at Overweight on device potential | 1 | Investing.com | ||
| 21.07. | Oppenheimer initiates Kestra Medical stock rating at Perform | 2 | Investing.com | ||
| 15.07. | Wolfe Research raises Kestra Medical stock price target on execution | 1 | Investing.com | ||
| 15.07. | BioPharma Credit PLC - NEW INVESTMENT IN KESTRA MEDICAL | - | RNS | ||
| 14.07. | KESTRA MEDICAL TECHNOLOGIES, LTD. - 10-K, Annual Report | 2 | SEC Filings | ||
| KESTRA MEDICAL TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 14.07. | Kestra Medical Technologies secures $200M loan facility | - | MassDevice | ||
| 14.07. | Kestra Medical übertrifft Umsatzprognosen, verzeichnet aber höheren Verlust als erwartet | 1 | Investing.com Deutsch | ||
| 14.07. | Kestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue Estimates | 1 | Zacks | ||
| 14.07. | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing | 220 | GlobeNewswire (Europe) | KIRKLAND, Wash., July 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced that it has entered... ► Artikel lesen | |
| 14.07. | KESTRA MEDICAL TECHNOLOGIES, LTD. - 8-K, Current Report | 2 | SEC Filings | ||
| 14.07. | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results | 769 | GlobeNewswire (Europe) | KIRKLAND, Wash., July 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results... ► Artikel lesen | |
| 30.06. | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies to Report Fourth Quarter Fiscal 2026 Financial Results on July 14 | 2 | GlobeNewswire (USA) | ||
| 11.05. | Kestra Medical: Piper Sandler bekräftigt Kaufempfehlung angesichts starker Umsatzdynamik | 1 | Investing.com Deutsch | ||
| 11.05. | Piper Sandler reiterates Kestra Medical stock rating on sales momentum | 1 | Investing.com | ||
| 09.04. | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner | 2 | GlobeNewswire (USA) | ||
| 07.04. | Kestra Medical stock price target reiterated at $32 by BTIG | 1 | Investing.com | ||
| 07.04. | BTIG bestätigt Kursziel für Kestra Medical bei 32 US-Dollar | - | Investing.com Deutsch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEARTFLOW | 49,890 | 0,00 % | Biotech Stocks At 52-Week Highs - Vogenx, Pharvaris, Solventum, Inhibikase Therapeutics, HeartFlow | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on August 24, 2026, driven by positive results from clinical trials or an upcoming conference participation. Vogenx... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 57,22 | -0,02 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| PROGYNY | 25,820 | 0,00 % | Progyny vor dem Boom?: Wells Fargo sieht bei dieser "Kinderwunsch-Aktie" 42 % Kurspotenzial | © Foto: SOPA Images - Sipa USAWells Fargo traut Progyny 42 Prozent Kurspotenzial zu. Das Geschäft mit Kinderwunsch-Leistungen könnte jetzt zum großen Wachstumstreiber werden Enthaltene Werte: US74340E1038Den... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 13,590 | 0,00 % | Aveanna Healthcare (AVAH) Just Ended A Four-Year Rate Fight | ||
| FRESENIUS | 46,445 | +1,31 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen Euro | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen... ► Artikel lesen | |
| AUTONOMIX MEDICAL | 7,190 | 0,00 % | Autonomix Medical more than doubles after $4.9M warrant deal; shares hit $11.63 | ||
| BILLIONTOONE | 100,02 | -0,06 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| PICARD MEDICAL | 9,500 | -0,31 % | Picard Medical, Inc.: Picard Medical Reports Second Quarter 2026 Financial Results | - Revenue Increases 39% and Net Loss Decreases 16%- Year-to-Date Revenue Increases 50%, with ~$0.9 Million in Gross Profit TUCSON, Ariz., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE... ► Artikel lesen | |
| GENEDX | 87,44 | +0,04 % | GeneDx study shows rapid genome sequencing benefits beyond ICUs | ||
| LIFESTANCE HEALTH GROUP | 12,280 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,600 | -0,25 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 13,595 | +0,04 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,750 | +0,97 % | Fresenius macht bei FMC Kasse - was jetzt zählt | ||
| CLEARPOINT NEURO | 16,990 | +0,18 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Reports Second Quarter 2026 Results | Positive BioPharma Partner Regulatory Progress and Early Success in Focused Ultrasound Technology Platform Expansion SOLANA BEACH, CA / ACCESS Newswire / August 3, 2026 / ClearPoint Neuro, Inc. (Nasdaq:CLPT)... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,200 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen |